Wolverine Trading
IPCI

Wolverine Trading’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Wolverine Trading’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,087
Closed -$31K – 5378
2016
Q4 		$31K Buy
+1,087
New +$30.4K ﹤0.01% 4280

Other funds holding IPCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $2.95B AUM 22.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return
VAM
Verity Asset Management Durham, North Carolina $238M AUM 24.8% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wolverine Trading's IPCI Position: Q1 2017 in Review

Wolverine Trading sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2017, closing a stake of 1,087 shares — an estimated $31K sold.

Wolverine Trading first reported a position in IPCI in Q4 2016 and held it in 1 quarter. The position peaked at $31K in Q4 2016. 22 funds tracked by Wall St. Rank hold IPCI as of Q1 2017.

  • Wolverine Trading reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2017 after selling out during the quarter.
  • Wolverine Trading sold 1,087 Intellipharmaceuticals International Inc. shares in Q1 2017, an estimated $31K.
  • Wolverine Trading first reported a position in Intellipharmaceuticals International Inc. in Q4 2016 and held it in 1 quarter.
  • Wolverine Trading's Intellipharmaceuticals International Inc. position peaked at $31K in Q4 2016.
  • 22 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2017.

Based on Wolverine Trading's 13F filing for Q1 2017, filed 15 May 2017.